Across TCGA pan-cancer cohorts, GAPDHP44 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated GAPDHP44 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher GAPDHP44 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP44 expression acts as an unfavorable survival marker, although some lineages such as READ and LUSC show a favorable association.

MESO, KICH, and LUAD are the cancer types where GAPDHP44 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.363	0.642	<.001	105	view →
KICH	DFS	Quartile	II,III,IV	0.500	1.000	.002	87	view →
LUAD	OS	Tertile	All	0.763	0.890	<.001	52	view →
READ	DFS	Tertile	III,IV	0.933	0.627	.002	48	view →
LIHC	OS	Quartile	II,III,IV	0.336	0.840	<.001	45	view →
KIRP	DFS	Median	All	0.426	0.824	.001	39	view →
LUSC	DFS	Tertile	II,III,IV	0.732	0.553	.008	31	view →
PAAD	DFS	Tertile	All	0.265	0.473	.003	23	view →
CHOL	DFS	Tertile	All	0.115	0.637	.003	23	view →
LAML	DFS	Quartile	All	0.640	0.328	.003	22	view →
LGG	DFS	Quartile	All	0.627	0.793	.003	18	view →
ACC	OS	Median	All	0.789	0.948	.010	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

Exploration

Same gene, other analysis: GAPDHP44 tumor-vs-normal RNA expression · all GAPDHP44 data types